Tofacitinib citrate Manufacturer/Cas:540737-29-9 /99.8% High purity CAS NO.540737-29-9
- FOB Price: USD: 2.00-3.00 /Metric Ton Get Latest Price
- Min.Order: 25 Metric Ton
- Payment Terms: L/C,T/T,
- Available Specifications:
100(1-25)Metric Ton100(25-500)Metric Ton
- Product Details
Keywords
- 540737-29-9
- Tofacitinib citrate
- Tofacitinibcitrate
Quick Details
- ProName: Tofacitinib citrate Manufacturer/Cas:5...
- CasNo: 540737-29-9
- Molecular Formula: C22H28N6O8
- Appearance: White or off white powder
- Application: It is suitable for chemical industry s...
- DeliveryTime: ccording to the actual situation
- PackAge: 100g/bag 1kg/bag 25kg/barrels
- Port: Shanghai port, shenzhen port, tianjin ...
- ProductionCapacity: 10000 Metric Ton/Day
- Purity: 99%
- Storage: 2 ℃, 25 ℃ dry dark cold storage
- Transportation: Air freight; shipping;DHL;FEDEX;TNT…
- LimitNum: 25 Metric Ton
- Related Substances: Refer to the details
- Residue on Ignition: Refer to the details
- Heavy Metal: ≤20ppm
- Valid Period: 24 month
- Dry weight lessness: ≤0.5%
Superiority
CAS:540737-29-9
Chinese Name: tropatinib citrate
Chinese alias: cittinib citrate; tuatatinib; TFA; citrate; aponitinib
English Name: tofacitinib citrate
English alias: Tofacitinib citrate; Tofacitinibcitrate; Xeljanz; CP-690550-10; Tasocitinib citrate;
CAS: 540737-29-9
Molecular formula: C22H28N6O8
Molecular weight: 504.49300
Exact mass: 504.19700 PSA:221.04000 LogP:0.23418
Purpose: scientific research.
Tolfatinib citrate is a drug for rheumatoid arthritis developed by Pfizer Pharmaceutical Company of the United States. It is named Xeljanz. It is used in adult patients with moderate to severe active rheumatoid arthritis (RA) who are not adequately or intolerably responsive to methotrexate treatment. This product is a Janus kinase inhibitor, taking two times a day.
Details